Serious Skincare Launch Proves Victorious at Evine
MINNEAPOLIS, Jan. 10, 2019 (GLOBE NEWSWIRE) — Evine Live Inc. (“Evine”) (NASDAQ:EVLV), a multiplatform interactive video and digital commerce company (evine.com), today […]
ABM Healthcare Achieves ISSA Cleaning Industry Management Standard and Green Building Certifications with Honors
CIMS and CIMS-GB Certifications Received Fourth Consecutive Time NEW YORK, Jan. 10, 2019 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a […]
Biome Grow subsidiary, Highland Grow secures purchase order with NSLC and sends first shipment of finished product
ANTIGONISH, Nova Scotia, Jan. 10, 2019 (GLOBE NEWSWIRE) — Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) […]
Green Thumb Industries (GTI) Awarded Ohio Processing License Allowing Company to Produce and Distribute Its Brands in the State
CHICAGO and VANCOUVER, British Columbia, Jan. 10, 2019 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF), […]
Western Uranium & Vanadium Corp. to Attend Vancouver Resource Investment Conference 2019
TORONTO and NUCLA, Colo., Jan. 10, 2019 (GLOBE NEWSWIRE) — Western Uranium & Vanadium Corp. (CSE: WUC) (OTCQX: WSTRF) (“Western” […]
Harsco Corporation Announces Timing of Fourth Quarter and Full Year 2018 Results and Conference Call
CAMP HILL, Pa., Jan. 10, 2019 (GLOBE NEWSWIRE) — Harsco Corporation (NYSE: HSC) today announced that it will issue its […]
Matinas BioPharma Announces a Research Evaluation with Top Global Pharma Company Based on Its Proprietary Drug Delivery Platform
– Matinas to formulate select oligonucleotides using its proprietary, lipid nano-crystal platform delivery technology – BEDMINSTER, N.J., Jan. 10, 2019 […]
Post Holdings Announces Redemption of 2.5% Series C Convertible Preferred Stock and Declares Dividend on Series C Convertible Preferred Stock
ST. LOUIS, Jan. 10, 2019 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE:POST) (the “Company” or “Post”) today announced it has […]
CEO Today honors Brunswick’s Schwabero among top U.S. executives for 2018
Mettawa, Ill., Jan. 10, 2019 (GLOBE NEWSWIRE) — – Mark Schwabero, recently retired chairman and chief executive officer of Brunswick […]
EMA Grants Orphan Drug Designation to Rafael Pharmaceuticals’ devimistat (CPI-613®) for Treatment of Metastatic Pancreatic Cancer
Newark, NJ, Jan. 10, 2019 (GLOBE NEWSWIRE) — Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based […]
